Concepedia

Jay Y. Spiegel

JY

34

Publications

3.2K

Citations

23

H-Index

2017

Active since

Affiliations

Stanford University(Current)

Stanford Medicine

University of Miami

The University of Texas MD Anderson Cancer Center

Moffitt Cancer Center

Jay Y. Spiegel is an author at Stanford University specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2017–2024

34

Publications

34

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Loretta J. Nastoupil, Michael D. Jain, Lei Feng et al. · Journal of Clinical Oncology · 2020 · 752 citations · Full text

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 537 citations · Full text

Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy

Zinaida Good, Jay Y. Spiegel, Bita Sahaf et al. · Nature Medicine · 2022 · 224 citations · Full text

, , +10

Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

John H. Baird, David J. Epstein, John Tamaresis et al. · Blood Advances · 2021 · 179 citations · Full text

Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial

Matthew J. Frank, Nasheed Hossain, Ali Bukhari et al. · Journal of Clinical Oncology · 2021 · 143 citations · Full text

Rows per page

1–5 of 34